HBI is operating in most markets around the world with a particular focus on Europe. By using a virtual organisation we are able to develop an entry plan for a specific country by finding the appropriate local expertise whether it be manufacturing, sales or regulatory.
Sambucol, our first brand, is a black elderberry extract which helps support the immune system. Sambucol is the only black elderberry extract to be clinically tested. Sambucol has now been sold to PharmaCare of Australia.
Erazaban is a new HBI brand and contains docosanol, an active which is the cold-sore market leader in the US. Having obtained a pan European OTC approval and launched the product in several markets, Erazaban rights in various markets have been sold to local partners.